Impact of Sleep Education Program on Glycemic Control in Hong Kong Chinese Type 2 Diabetic Patients
1 other identifier
interventional
264
2 countries
2
Brief Summary
This is a randomized controlled trial with 12 month sleep education as intervention, followed by a 12 month observational period, to study whether sleep education would improve glycemic control and cardiometabolic profile of sleep deprived type 2 diabetic patients and evaluate the neurohormonal changes associated with sleep education.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable type-2-diabetes-mellitus
Started May 2013
Longer than P75 for not_applicable type-2-diabetes-mellitus
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 18, 2011
CompletedStudy Start
First participant enrolled
May 1, 2013
CompletedFirst Posted
Study publicly available on registry
June 20, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedJune 20, 2013
June 1, 2013
3.6 years
October 18, 2011
June 19, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Change in HbA1c from baseline
12 months
Secondary Outcomes (6)
fasting plasma glucose
12 months
insulin resistance
12 months
body weight
12 months
blood pressure
12 months
lipid profile
12 months
- +1 more secondary outcomes
Study Arms (2)
Usual Care
NO INTERVENTIONsleep education program
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Aged 18-65 years
- Type 2 diabetes mellitus
- Chinese ethnicity
- Able and willing to give informed written consent
- Sleep deprived, defined as subjective sleeping time \<6 hours per day
You may not qualify if:
- Type 1 diabetes mellitus
- Known history of psychiatric disorders (e.g. depression, anxiety, dementia)
- Sleep disorders secondary to another medical condition (e.g. obstructive sleep apnoea (OSA), circadian rhythm sleep disorder)
- Concomitant chronic medical condition that was likely to be the cause of sleep problem (e.g. benign prostatic hypertrophy, chronic pain)
- Concurrent use of hypnotic drugs, psychotic medications and any drugs that are known to affect sleep.
- Any condition, as judged by the investigators, as ineligible to participate in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
The Chinese University of Hong Kong
Hong Kong, Hong Kong, China
Clinical Trial Centre, The Chinese University of Hong Kong, Prince of Wales Hospital
Hong Kong, Hong Kong, Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alice PS Kong, FRCP
Chinese University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 18, 2011
First Posted
June 20, 2013
Study Start
May 1, 2013
Primary Completion
December 1, 2016
Study Completion
December 1, 2017
Last Updated
June 20, 2013
Record last verified: 2013-06